Cargando…

The Risk of Acute Kidney Injury in Hepatitis B Virus-Related Acute on Chronic Liver Failure with Tenofovir Treatment

AIMS: Tenofovir (TDF) is an antiviral drug with potential risk of kidney injury. The study is aimed at comparing the incidence of acute kidney injury (AKI) between TDF and entecavir (ETV) treatment in hepatitis B virus- (HBV-) related acute on chronic liver failure (ACLF). METHODS: Treatment-naive p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Kai, Lin, Su, Wang, Mingfang, Huang, Jiaofeng, Zhu, Yueyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273491/ https://www.ncbi.nlm.nih.gov/pubmed/32596332 http://dx.doi.org/10.1155/2020/5728359

Ejemplares similares

Prognostic nomogram for acute-on-chronic hepatitis B liver failure
por: Lin, Su, et al.
Publicado: (2017)

The Association between Meteorological Factors and the Prevalence of Acute-on-chronic Liver Failure: A Population-based Study, 2007–2016
por: Lin, Su, et al.
Publicado: (2019)

Role of tenofovir and telbivudine in treatment of hepatitis B related acute on chronic liver failure
por: Malakar, Debraj, et al.
Publicado: (2021)

Antiviral Therapy in Chronic Hepatitis B With Mild Acute Exacerbation
por: Lin, Su, et al.
Publicado: (2017)

Fatty liver disease reverses the obesity paradox in chronic kidney disease stages 3–5: A follow‐up study of NHANES III
por: Huang, Jiaofeng, et al.
Publicado: (2022)

Comparative role of tenofovir versus entecavir for treating patients with hepatitis B virus-related acute on chronic liver failure
por: Hossain, Sharker M. S., et al.
Publicado: (2021)

Observational study on the response of tenofovir monotherapy versus tenofovir plus telbivudine dual therapy in patients with hepatitis B virus related acute on chronic liver failure
por: Manik, Abul H, et al.
Publicado: (2021)

Expression and Clinical Significance of Decoy Receptor 3 in Acute-on-Chronic Liver Failure
por: Lin, Su, et al.
Publicado: (2019)

Tenofovir alafenamide versus entecavir for treating hepatitis B virus-related acute-on-chronic liver failure: real-world study
por: Peng, Wenting, et al.
Publicado: (2023)

Syphilitic hepatitis: a case report and review of the literature
por: Huang, Jiaofeng, et al.
Publicado: (2019)

Authors response to correspondence regarding paper entitled Syphilitic hepatitis: a case report and review of the literature
por: Huang, Jiaofeng, et al.
Publicado: (2020)

Hemorrhagic Complications Following Abdominal Paracentesis in Acute on Chronic Liver Failure: A Propensity Score Analysis
por: Lin, Su, et al.
Publicado: (2015)

Short-term and long-term safety and efficacy of tenofovir alafenamide, tenofovir disoproxil fumarate and entecavir treatment of acute-on-chronic liver failure associated with hepatitis B
por: Li, Juan, et al.
Publicado: (2021)

A severe case of tenofovir-associated acute kidney injury requiring hemodialysis in a patient with chronic hepatitis B
por: Cho, A Young, et al.
Publicado: (2020)

The association between vitamin D-related gene polymorphisms and hepatitis B virus-related liver cirrhosis
por: Wu, Jiali, et al.
Publicado: (2020)

Determination of HMGB1 in hepatitis B virus-related acute-on-chronic liver failure patients with acute kidney injury: Early prediction and prognostic implications
por: Liu, Yu, et al.
Publicado: (2023)

Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B
por: Gerada, Jurgen, et al.
Publicado: (2013)

A Randomized Controlled Trial of Glycyrrhizin Plus Tenofovir vs. Tenofovir in Chronic Hepatitis B with Severe Acute Exacerbation
por: Hung, Chao-Hung, et al.
Publicado: (2017)

Acute Kidney Injury in a Patient on Tenofovir Alafenamide Fumarate After Initiation of Treatment for Hepatitis C Virus Infection
por: Serota, David P, et al.
Publicado: (2018)

Predictive value of the Chinese group on the study of severe hepatitis B-acute-on-chronic liver failure score in the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure
por: Tong, Jing-Jing, et al.
Publicado: (2019)

Efficacy and safety of tenofovir disoproxil fumarate versus entecavir in the treatment of acute-on-chronic liver failure with hepatitis B: a systematic review and meta-analysis
por: Wang, Neng, et al.
Publicado: (2023)

Is Toxoplasma gondii infection correlated with nonalcoholic fatty liver disease?- a population-based study
por: Huang, Jiaofeng, et al.
Publicado: (2018)

Prediction model of the progression of patients with acute deterioration of hepatitis B virus-related chronic liver disease to acute-on-chronic liver failure
por: Li, Chen, et al.
Publicado: (2018)

Procalcitonin and Liver Disease: A Literature Review
por: Dong, Ruolin, et al.
Publicado: (2018)

Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
por: Yim, Hyung Joon
Publicado: (2016)

A Systematic Literature Review of Syphilitic Hepatitis in Adults
por: Huang, Jiaofeng, et al.
Publicado: (2018)

Glucocorticoid Regulates NLRP3 in Acute-On-Chronic Hepatitis B Liver Failure
por: Zhao, Qian, et al.
Publicado: (2019)

Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis
por: Jiang, Qun-Qun, et al.
Publicado: (2018)

Acute kidney injury in patients with acute-on-chronic liver failure: clinical significance and management
por: Yoo, Jeong-Ju, et al.
Publicado: (2023)

Soluble mannose receptor as a predictor of prognosis of hepatitis B virus-related acute-on-chronic liver failure
por: Li, Tai-Ping, et al.
Publicado: (2019)

Risk factors for progression to acute-on-chronic liver failure during severe acute exacerbation of chronic hepatitis B virus infection
por: Yuan, Ling, et al.
Publicado: (2019)

Role of Hepatitis E Virus Infection in Acute-on-Chronic Liver Failure
por: Frias, Mario, et al.
Publicado: (2018)

The clinical parameters for the diagnosis of hepatitis B virus related acute-on-chronic liver failure with sepsis
por: Xue, Ran, et al.
Publicado: (2019)

Impact of the Gut Microbiome on the Progression of Hepatitis B Virus Related Acute-on-Chronic Liver Failure
por: Yao, Xuebing, et al.
Publicado: (2021)

Short-term prognostic factors for hepatitis B virus-related acute-on-chronic liver failure
por: Ye, Qiao-Xia, et al.
Publicado: (2022)

Clinical Prediction Models for Hepatitis B Virus-related Acute-on-chronic Liver Failure: A Technical Report
por: Yu, Xia, et al.
Publicado: (2021)

Intrahepatic macrophage reprogramming associated with lipid metabolism in hepatitis B virus-related acute-on-chronic liver failure
por: Peng, Bo, et al.
Publicado: (2023)

Factors Prognostic of Survival in Liver Transplant Recipients with Hepatitis B Virus Related Acute-on-Chronic Liver Failure
por: Zhou, Zhengjun, et al.
Publicado: (2022)

Liver volume based prediction model for patients with hepatitis B virus‐related acute‐on‐chronic liver failure
por: Hu, Chunhua, et al.
Publicado: (2022)

Validation of Non-invasive Fibrosis Scores for Predicting Advanced Fibrosis in Metabolic-associated Fatty Liver Disease
por: Chen, Xiaoning, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mvcv76iiiq2jlh7c1vfmljou4p